I’ve been staying away from the board (other tha

I’ve been staying away from the board (other than to read highly recommended posts) because there just isn’t much to say positive or negative since in fact, we do not actually know what is going on behind the scenes – everyone here is speculating. But I’m getting a sense that people are expecting big things because of the back to back CC’s this week. That makes no sense to me at all at this point.

I have come to believe that nothing, and I mean NOTHING, is going to come out of the CCs that materially affects the pps. Joe could say it is now believed that AE37 cures cancer and the pps would not change. I think there are only two things that will affect pps for these two companies, and one probably won’t affect the other.

The NGIO spinout will create a value for NGIO shares. Hopefully, it will be in the multi-billion range, which will land NGIO at $5/share or above. This will happen, eventually, but nothing in the CC on Thurs will accelerate it. And for what it’s worth, I now believe that even this event will not affect GNBT’s share price. Yes, there will be a huge asset on GNBT’s books (maybe even something that can remove the going concern notice), but that does not mean it will translate to a pps rise. There may be a temporary bump, but it likely won’t be large and it won’t be long term. We saw this with the retirement of 20 million shares of GNBT – nadda, nyet, nothing happened with the pps. So why should an addition to the books make a difference?

What will make a difference? S1 funding? Nope – at least, not directly. Again, I believe there will a small bump in pps with the announcement of any of the S1 registrations, but it won’t last either. What will make a difference is once Joe gets funding, and he can further the subsidiaries to a point they start showing GROWING revenue, THEN we’ll see GNBT’s pps start a sustained upturn.
But that isn’t happening Wed, nor next month or probably throughout the 4th quarter this year. If we receive S1 approval in the next couple of months, I would expect at least another year before the funding can flow through to develop the businesses and start seeing actual revenues. So next year is the earliest I see GNBT’s pps doing anything, and even that might be optimistic.

Does this mean I think Joe isn’t doing all he can to increase value for shareholders? Nope – based on recent PRs, he has truly knitted a silk purse out of a sow’s ear. But it hasn’t and won’t matter - there is something going on behind the OTC scene that holds GNBT share price down. Bad actors, lack of interest or trust, market makers screwing around between themselves for whatever purposes? I don’t know, and it doesn’t make much difference if I did know because there’s nothing I or you can do about it. The news on GNBT has been such that it should rise, but it doesn’t. That is all that matters, and using that history, I’m projecting it to continue until Joe can fund the subsidiaries and they can establish their own worth.

NGIO will be different – it will trade on emotion (hope or fear) once it is uplisted. Sorry to those here that currently don’t have NGIO shares from the dividends; if you only have GNBT shares, you’ll have longer to wait for a payoff. I still think it will come, but it won’t be Wednesday, Thursday, next month or even early next year. If I’m right, you’ll have to make the decision do you want to keep holding for the turnaround, or are there better, more well thought of stocks (CYDY?) that you should be investing in.

My opinion only, mileage will vary.